These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37936540)

  • 1. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
    Rajagopalan K; Rashid N; Gopal D; Doshi D
    Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care resource utilization patterns among patients with Parkinson's disease psychosis: analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
    Rajagopalan K; Rashid N; Kumar S; Doshi D
    J Med Econ; 2023; 26(1):34-42. PubMed ID: 36444507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients treated with pimavanserin or quetiapine for Parkinson's disease psychosis: analysis of health resource utilization patterns among Medicare beneficiaries.
    Rajagopalan K; Rashid N; Doshi D
    J Med Econ; 2023; 26(1):769-776. PubMed ID: 37272069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.
    Rajagopalan K; Rashid N; Gopal D; Doshi D
    J Comp Eff Res; 2024 Jul; 13(7):e240038. PubMed ID: 38850129
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis.
    Rajagopalan K; Rashid N; Doshi D
    J Comp Eff Res; 2024 Jan; 13(1):e230114. PubMed ID: 38099518
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson's Disease Psychosis.
    Rajagopalan K; Rashid N; Yakkala V; Doshi D
    Clinicoecon Outcomes Res; 2024; 16():149-159. PubMed ID: 38495124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of illness among patients with dementia-related psychosis.
    Frazer M; Abler V; Halpern R; Skoog B; Rashid N
    J Manag Care Spec Pharm; 2021 Mar; 27(3):367-378. PubMed ID: 33645238
    [No Abstract]   [Full Text] [Related]  

  • 8. Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: Retrospective cohort study.
    Wetmore JB; Li S; Yan H; Irfan M; Rashid N; Peng Y; Gilbertson DT; Shim A
    Parkinsonism Relat Disord; 2019 Nov; 68():95-101. PubMed ID: 31679990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of post-acute care in skilled nursing facilities in Medicare beneficiaries with and without a diagnosis of dementia.
    Burke RE; Xu Y; Ritter AZ
    J Am Geriatr Soc; 2021 Oct; 69(10):2899-2907. PubMed ID: 34173231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings.
    Neuenschwander JF; Silverstein AR; Teigland CL; Kumar S; Zeng EY; Agiro AT; Pottorf WJ; Peacock WF
    Adv Ther; 2023 Mar; 40(3):1204-1223. PubMed ID: 36652174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation.
    Deitelzweig S; Luo X; Gupta K; Trocio J; Mardekian J; Curtice T; Lingohr-Smith M; Menges B; Lin J
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1191-1201. PubMed ID: 29083968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals.
    Best JH; Reddy SR; Chang E; Bognar K; Tarbox MH; Cagas SE; Seetasith A
    J Med Econ; 2024; 27(1):240-252. PubMed ID: 38294309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis.
    Vetrovec GW; Lim MJ; Needham KA
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):703-710. PubMed ID: 32790231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and economic burden of Lewy body dementia in the United States.
    Desai U; Chandler J; Kirson N; Georgieva M; Cheung HC; Westermeyer B; Lane H; Biglan K
    Curr Med Res Opin; 2022 Jul; 38(7):1177-1188. PubMed ID: 35442134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs.
    Gerds AT; Yu J; Shah A; Xi A; Kumar S; Scherber R; Parasuraman S
    J Med Econ; 2023; 26(1):843-849. PubMed ID: 37294103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.
    Jain R; Fu AC; Lim J; Wang C; Elder J; Sander SD; Tan H
    J Manag Care Spec Pharm; 2018 Jan; 24(1):73-82. PubMed ID: 29290177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries.
    Gandhi AB; Onukwugha E; Albarmawi H; Johnson A; Myers DE; Gray D; Alvir J; Hynicka L; Shulman LM
    Neurology; 2021 Aug; 97(6):e597-e607. PubMed ID: 34045274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
    J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.